OptimizeRx Corporation - Common Stock (OPRX)
8.9500
-0.4000 (-4.28%)
NASDAQ · Last Trade: Nov 12th, 2:27 AM EST
News & Press Releases
OptimizeRx (OPRX) Q3 2026 Earnings Call Transcriptfool.com
Margins jumped as revenue slipped, and the 2027 pipeline is picking up.
Via The Motley Fool · November 12, 2026
What OptimizeRx (OPRX) Said on Its Q3 Earnings Callmarketbeat.com
OptimizeRx (NASDAQ:OPRX) lowered its 2026 revenue outlook after third-quarter sales fell 17%, even as cost reductions and a favorable product mix helped the healthcare marketing technology company increase profitability.
The company now expects full-year revenue of $87 million to $93 million, while
Via MarketBeat · November 11, 2026
OptimizeRx (NASDAQ:OPRX) Shares Fall on Reduced 2026 Revenue Guidance Despite Q3 EPS Beatchartmill.com
Via Chartmill · November 11, 2026
After-Hours Movers: Gainers and Losers From the November 11, 2026 US Sessionchartmill.com
Via Chartmill · November 11, 2026
OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidancechartmill.com
Via Chartmill · May 12, 2026
OptimizeRx Reports Third Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
WALTHAM, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the three months ended September 30, 2026.
By OptimizeRx Corporation · Via GlobeNewswire · November 11, 2026
OptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ET
WALTHAM, Mass., Oct. 28, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at critical decision points, will hold a conference call on Wednesday, November 11, 2026, at 4:30 p.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2026. The financial results will be issued in a press release prior to the call.
By OptimizeRx Corporation · Via GlobeNewswire · October 28, 2026
OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel
Latest DSP integration expands buyer access to OptimizeRx point of care inventory through existing programmatic workflows
By OptimizeRx Corporation · Via GlobeNewswire · October 27, 2026
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
Expands programmatic access to 800,000 verified prescribers directly in the EHR workflow, making OptimizeRx’s point of care inventory directly available to advertisers using The Trade Desk
By OptimizeRx Corporation · Via GlobeNewswire · September 22, 2026
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
New functionality helps DSPs and agency planners create deterministic HCP and consumer audiences faster, using one single workflow
By OptimizeRx Corporation · Via GlobeNewswire · September 14, 2026
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced that management will participate in the 10th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September 10, 2026, in New York, NY.
By OptimizeRx Corporation · Via GlobeNewswire · September 8, 2026
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
Experienced pharmaceutical and healthcare executive joins advisory board to help accelerate innovation and strengthen life sciences marketing technology
By OptimizeRx Corporation · Via GlobeNewswire · September 2, 2026
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcriptfool.com
AI software revenue grew 25% despite overall quarterly decline from customer inactivity.
Via The Motley Fool · August 19, 2026
OptimizeRx Q2 Earnings Call Highlightsmarketbeat.com
OptimizeRx (NASDAQ:OPRX) reported second-quarter fiscal 2026 revenue of $20.5 million, down 30% from $29.2 million a year earlier, while adjusted EBITDA totaled $4.9 million, management said on its earnings call. The company reaffirmed its full-year revenue outlook of $95 million to $100 million and
Via MarketBeat · August 12, 2026
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
The Company Names Andy D’Silva as the next Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027
By OptimizeRx Corporation · Via GlobeNewswire · August 12, 2026
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
– Q2 revenue totals $20.5 million– Q2 net loss and adjusted EBITDA of $(0.7) million and $4.9 million, respectively– Reaffirms fiscal year 2026 revenue guidance of $95 - $100 million and adjusted EBITDA guidance of $21 - $25 million– Completed debt refinancing with $35 million traditional banking facility, including $25 million term loan and $10 million undrawn revolver; repaid $8.3 million of principal since inception
By OptimizeRx Corporation · Via GlobeNewswire · August 12, 2026
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
WALTHAM, Mass., July 29, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at the most important decision points, will hold a conference call on Wednesday, August 12, 2026, at 4:30 p.m. Eastern Time to discuss its results for the second quarter period ended June 30, 2026. The financial results will be issued in a press release prior to the call.
By OptimizeRx Corporation · Via GlobeNewswire · July 29, 2026
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
Leading pharmaceutical marketing executive joins leadership team to accelerate innovation and strengthen partnerships across the life sciences industry
By OptimizeRx Corporation · Via GlobeNewswire · July 23, 2026
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
Enhanced technology delivers brand savings offers directly within the prescribing workflow, when HCP intent is highest
By OptimizeRx Corporation · Via GlobeNewswire · June 30, 2026
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, verified HCP audiences using natural-language prompts
By OptimizeRx Corporation · Via GlobeNewswire · June 25, 2026
MissionIRNewsBreaks – OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
OptimizeRx (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility consists of a $25 million term loan and a $10 million revolving credit facility that was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction.
Via Investor Brand Network · June 11, 2026
OptimizeRx to Participate in Upcoming Investor Conferences
WALTHAM, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:
By OptimizeRx Corporation · Via GlobeNewswire · June 1, 2026
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
Powered by OptimizeRx’s new programmatic infrastructure, collaboration expands access to premium point of care inventory for life sciences marketers
By OptimizeRx Corporation · Via GlobeNewswire · May 21, 2026
OptimizeRx (OPRX) Q1 2026 Earnings Transcriptfool.com
OptimizeRx (OPRX) Q1 2026 Earnings Transcript
Via The Motley Fool · May 14, 2026
OptimizeRx Q1 Earnings Call Highlightsmarketbeat.com
OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life sciences customers and shorter contract commitments tied in part to most-favored-nation pricing dynamics
Via MarketBeat · May 12, 2026